ELV vs VRTX · P/E 18, rev $199.13B vs P/E 30, rev $3.33B
Elevance Health Inc (ELV) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ELV and VRTX stock pages for the full models.
Not investment advice.